Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference

被引:91
作者
Jiang, W-Q [1 ]
Zhong, Z-H [1 ]
Henson, J. D. [1 ]
Reddel, R. R. [1 ]
机构
[1] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW 2145, Australia
关键词
telomeres; alternative lengthening of telomeres; ALT-associated PML bodies; PML; siRNA; methionine restriction; PROMYELOCYTIC LEUKEMIA BODIES; LARGE-BODY FORMATION; TUMOR-CELL-LINES; DNA-DAMAGE; MAMMALIAN-CELLS; METABOLIC DEFECT; PROTEIN COMPLEX; NUCLEAR-BODIES; CANCER-CELLS; HUMAN RAP1;
D O I
10.1038/sj.onc.1210260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Telomerase-negative cancer cells can maintain their telomeres by a recombination-mediated alternative lengthening of telomeres (ALT) process. We reported previously that sequestration of MRE11/RAD50/NBS1 complexes represses ALT-mediated telomere length maintenance, and suppresses formation of ALT-associated promyelocytic leukemia (PML) bodies (APBs). APBs are PML bodies containing telomeric DNA and telomere-binding proteins, and are observed only in a small fraction of cells within asynchronously dividing ALT-positive cell populations. Here, we report that methionine restriction caused a reversible arrest in G(0)/G(1) phase of the cell cycle and reversible induction of APB formation in most cells within an ALT-positive population. We combined methionine restriction with RNA interference to test whether the following proteins are required for APB formation: PML body-associated proteins, PML and Sp100; telomere-associated proteins, TRF1, TRF2, TIN2 and RAP1; and DNA repair proteins, MRE11, RAD50, NBS1 and 53BP1. APB formation was not decreased by depletion of Sp100 (as reported previously) or of 53BP1, although 53BP1 partially colocalizes with APBs. Depletion of the other proteins suppressed APB formation. Because of the close linkage between ALT-mediated telomere maintenance and ability to form APBs, the eight proteins identified by this screen as being required for APB formation are also likely to be required for the ALT mechanism. Oncogene
引用
收藏
页码:4635 / 4647
页数:13
相关论文
共 65 条
[1]   Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage [J].
Anderson, L ;
Henderson, C ;
Adachi, Y .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (05) :1719-1729
[2]   Replication licensing - defining the proliferative state? [J].
Blow, JJ ;
Hodgson, B .
TRENDS IN CELL BIOLOGY, 2002, 12 (02) :72-78
[3]   Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: Effect of ectopic hTERT [J].
Brachner, A ;
Sasgary, S ;
Pirker, C ;
Rodgarkia, C ;
Mikula, M ;
Mikulits, W ;
Bergmeister, H ;
Setinek, U ;
Wieser, M ;
Chin, SF ;
Caldas, C ;
Micksche, M ;
Cerni, C ;
Berger, W .
CANCER RESEARCH, 2006, 66 (07) :3584-3592
[4]   TELOMERE ELONGATION IN IMMORTAL HUMAN-CELLS WITHOUT DETECTABLE TELOMERASE ACTIVITY [J].
BRYAN, TM ;
ENGLEZOU, A ;
GUPTA, J ;
BACCHETTI, S ;
REDDEL, RR .
EMBO JOURNAL, 1995, 14 (17) :4240-4248
[5]   Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines [J].
Bryan, TM ;
Englezou, A ;
DallaPozza, L ;
Dunham, MA ;
Reddel, RR .
NATURE MEDICINE, 1997, 3 (11) :1271-1274
[6]   A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT [J].
Cerone, MA ;
Autexier, C ;
Londoño-Vallejo, JA ;
Bacchetti, S .
ONCOGENE, 2005, 24 (53) :7893-7901
[7]   Shelterin: the protein complex that shapes and safeguards human telomeres [J].
de Lange, T .
GENES & DEVELOPMENT, 2005, 19 (18) :2100-2110
[8]   Protection of mammalian telomeres [J].
de Lange, T .
ONCOGENE, 2002, 21 (04) :532-540
[9]   Telomere maintenance by recombination in human cells [J].
Dunham, MA ;
Neumann, AA ;
Fasching, CL ;
Reddel, RR .
NATURE GENETICS, 2000, 26 (04) :447-450
[10]   Merase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies [J].
Fasching, CL ;
Bower, K ;
Reddel, RR .
CANCER RESEARCH, 2005, 65 (07) :2722-2729